In Brief: Excimer laser seizures
This article was originally published in The Gray Sheet
Excimer laser seizures: FDA issues Talk Paper Oct. 22 detailing the seizures of unapproved excimer lasers that were being used for vision correction surgery. FDA notes that U.S. marshals have seized unapproved lasers from five locations ("The Gray Sheet" Oct. 13, In Brief). Twenty-four warning letters have been issued in the past three years to manufacturers and physicians regarding the sale and use of unapproved excimer lasers, FDA says...
You may also be interested in...
Oxford University/AstraZeneca’s COVID-19 vaccine cuts the spread of the virus by 60%, apart from having 70% efficacy in reducing infections in vaccinated individuals. While that is good news for their Indian partner, Serum Institute, the 90% efficacy shown in a subset due to a dosing error causes a dilemma.
After announcing positive topline Phase II results for its Alzheimer’s candidate late last year, Korea's GemVax releases additional data showing significant improvement in secondary outcomes, further raising expectations for the novel peptide drug.
The US FDA’s decision to ask on device adverse event reports whether the device involved had been serviced by a third party could help the agency as well as device makers, says Ricki Chase, compliance practice director at Lachman Consultant Services.